Posted by: SomaNews on: 19 Sep, 2009
First Doses of Swine Flu Vaccine Coming Soon
The first 3.4 million doses of swine flu vaccine — all the FluMist nasal spray vaccine — will ship in early October. Some flu shots may be ready by then, too, with more on the way.
Posted by: SomaNews on: 19 Sep, 2009
Heart Risk Factors Cut Life Span by 10 Years
A 50-year-old smoker who has a history of high blood pressure and high cholesterol can expect to die a decade earlier than someone of the same age with none of these heart disease risk factors, a study shows.
Posted by: SomaNews on: 19 Sep, 2009
Ultrasound Eyebrow Lift Device OK’d
The FDA has cleared a new ultrasound eyebrow lift device, called the Ulthera System, for use by doctors, according to the device’s maker.
Posted by: SomaNews on: 19 Sep, 2009
2 Easiest Ways to Catch Swine Flu
Aside from having someone cough on your face, the easiest way to get the flu is to touch your eyes, nose, or mouth with unwashed hands, a risk-analysis study suggests.
Posted by: SomaNews on: 19 Sep, 2009
Teva Provides Update For QVAR
Study demonstrates that QVAR is more cost-effective than other inhaled corticosteroid (ICS) asthma therapy options
Posted by: SomaNews on: 19 Sep, 2009
InVitria Completes Beta Testing Of Optiferrin For Mammalian Cell Culture
Optiferrin shown to provide superior performance in cell culture
Posted by: SomaNews on: 19 Sep, 2009
Genentech Provides Positive Data For Phase III Study For Rituxan
Study showed patients lived longer without low-grade lymphoma progressing when Rituxan was used as first-line treatment for maintenance
Posted by: SomaNews on: 19 Sep, 2009
Ranbaxy In-licenses Cosmetic Product For indian Market
Botulinum Toxin Type -A, an anti-ageing medicine, is used in the correction of facial wrinkles and hyperhidrosis
Posted by: SomaNews on: 19 Sep, 2009
Intarcia Initiates Enrollment Of ITCA 650 Phase 2 Diabetes Study
Byetta, an FDA-approved twice-daily injection form of exenatide
Posted by: SomaNews on: 19 Sep, 2009
Bolder Receives $1.2m NIH Grant
For the development of long-acting EPO analog for chronic kidney disease
Recent Comments